Antiestrogenic Effects of the Novel Sphingosine Kinase-2 Inhibitor ABC294640
James W. Antoon(Tulane University), Barbara S. Beckman(Tulane University)
Cited by 114
Related Papers
Pharmacological inhibition of sphingosine kinase isoforms alters estrogen receptor signaling in human breast cancer
|Journal of Molecular Endocrinology|2011|49
Altered Death Receptor Signaling Promotes Epithelial-to-Mesenchymal Transition and Acquired Chemoresistance
|Scientific Reports|2012|37